a:head bio AG
Facts
- Founded
- 2019
- Staff
- 9
- Organization type
- RDM biotech/pharma
- Region
- Vienna
- Focus
- human health
Profile
a:head aims to develop new therapeutics for the treatment of brain disorders based on human cerebral organoids
R&D:a:head’s drug discovery approach is based on human cerebral organoids, a revolutionary, paradigm-shifting new technology that allows the generation of mini brains from human stem cells in vitro. They capture the essential aspects of human embryonic brain development including brain patterning, formation of brain ventricles, differentiation into the various neuronal and supportive cell types and their correct three-dimensional arrangement.
Similar companies in RDM biotech/pharma
Takeda in Austria
- Organization type
- RDM biotech/pharma
- Cluster
- LISAvienna
- Focus
- human health
Merck Sharp
- Organization type
- RDM biotech/pharma
- Region
- Vienna
- Cluster
- LISAvienna
- Focus
- industrial processing
TissueGnostics GmbH
- Organization type
- RDM biotech/pharma
- Region
- Vienna
- Cluster
- LISAvienna
AlgOss Biotechnologies GmbH
- Organization type
- RDM biotech/pharma
- Region
- Vienna
- Cluster
- LISAvienna
- Focus
- human health
Contact
Dr.-Bohr-Gasse 7, VBC6
1030 Wien
Vienna
Contact: Oliver Szolar (CEO)
Email: office@aheadbio.com
Website